RAG2-/-, IκB-α-/- chimeras display a psoriasiform skin disease

Journal of Investigative Dermatology

Volumn 115, Issue 6, 2000, Pages 1124-1133

  Chen, Chih Li ^a   Yull, Fiona E ^a   Cardwell, Nancy ^a   Singh, Nagendra ^a   Strayhorn, William David ^a   Nanney, Lillian B ^a   Kerr, Lawrence D ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

I B ; Keratinocytes; Lymphocytes; Psoriasis

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATITIS; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; LETHALITY; LYMPHOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; SKIN GRAFT;

EID: 0034519024     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00162.x     Document Type: Article

References (60)

1. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
2. Coordinate regulation of immune and inflammanatory responses by cytokines
3. The NF-kappa B and I kappa B proteins: New discoveries and insights
4. Psoriasis
5. The acute phase response
6. Tumor necrosis factor and interleukin-I lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation
7. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice
8. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets
9. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
10. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions
11. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF) -kappaB
12. HIV-1 in the developing CNS developmental differences in gene expression
13. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis
14. Apoptosis in proliferating, senescent, and immortalized keratinocytes
15. Analysis of gene function in lymphocytes by B, AG-2-deficient blastocyst complementation
16. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases
17. RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development
18. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice
19. The immunopathology of psoriasis
20. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype
21. T helper cell I-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
22. Immunology of AIDS related to psoriasis
23. Transplantation of psoriatic skin onto nude mice
24. Ultraviolet radiation increases HIV-long terminal repeat-directed expression in transgenic mice
25. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
26. Response of psoriasis to a lymphocyte-selective toxin (DABS 891L-2) suggests a primary immune, but not keratinocyte, pathogenic basis
27. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis
28. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65
29. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice
30. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50
31. AIDS exacerbates psoriasis
32. IkappaBalpha defciency results in a sustained NF-kappaB response and severe widespread dermatitis in mice
33. Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice
34. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells
35. IKK1-deficient mice exhibit abnormal development of skin and skeleton
36. Serial cultivation of epidermal keratinocytes from psoriatic plaques
37. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
38. Embryonic stem cells lacking a functional inhibitory G-protein subunit (alpha i2) produced by gene targeting of both alleles
39. Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation
40. Epidermal growth factor receptors in idiopathic and vitally induced skin diseases
41. Intraepidermal psoriatic cytokine network involves gamma interferon, transforming growth factor-alpha, and their cell surface receptors: Dysregulation rather than deficiency
42. The cytokine network in psoriasis
43. Pathogenesis and immunointervention strategies for psoriasis
44. The immunologic and genetic basis of psoriasis
45. Animal models of psoriasis
46. Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model
47. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161
48. Human macrophage inflammatory protein alpha (MIP-I alpha) and MIP-I beta chemokines attract distinct populations of lymphocytes
49. Animal models of psoriasis - What can we learn from them?
50. Essential role of T cell NF-kappa B activation in collagen-induced arthritis
51. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB
52. Regulation of immune responses by NF-kappa B/Rel transcription factor
53. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses
54. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
55. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes
56. Full-thickness skin grafts from flaky skin mice to nude mice: Maintenance of the psoriasiform phenotype
57. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis
58. Dermal injection of immunocytes induces psoriasis
59. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin